Docoh
Loading...

ACU Acme United

Filed: 6 Aug 21, 4:01pm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2021

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from:                       to                 

Commission file number: 01-07698

ACME UNITED CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

Connecticut

 

06-0236700

State or Other Jurisdiction of

 

I.R.S. Employer Identification No.

Incorporation or Organization

 

 

 

 

 

1 Waterview Drive, Shelton, Connecticut

 

06484

Address of Principal Executive Offices

 

Zip Code

 

Registrant's telephone number, including area code: (203) 254-6060

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol

Name of each exchange on which registered

$2.50 par value Common Stock

ACU

NYSE American

Indicate by check mark whether the registrant (l) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes       No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes       No  

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check one).

 

Large accelerated filer

 

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

Smaller Reporting Company

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(s) of the Exchange Act

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes       No  

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes       No  

 

Registrant had 3,538,708 shares of its $2.50 par value Common Stock outstanding as of August 2, 2021.

 

 

 


 

 

ACME UNITED CORPORATION

INDEX

 

 

 

Page

Number

 

 

 

Part I — FINANCIAL INFORMATION:

 

Item 1:

Financial Statements (Unaudited)

3

 

Condensed Consolidated Balance Sheets at June 30, 2021 and December 31, 2020

3

 

Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2021 and 2020

5

 

Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2021 and 2020

6

 

Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and six months ended June 30, 2021 and 2020

7

 

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2021 and 2020

9

 

Notes to Condensed Consolidated Financial Statements

10

Item 2:

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 3: 

Quantitative and Qualitative Disclosures about Market Risk

20

Item 4: 

Controls and Procedures

20

 

 

 

Part II — OTHER INFORMATION:

 

Item 1:   

Legal Proceedings

21

Item 1A:

Risk Factors

21

Item 2:   

Unregistered Sales of Equity Securities and Use of Proceeds

21

Item 3:   

Defaults Upon Senior Securities

21

Item 4:   

Mine Safety Disclosures

21

Item 5:   

Other Information

21

Item 6:  

Exhibits

21

Signatures

22

 

2


 

 

Part I - FINANCIAL INFORMATION

 

Item 1: Financial Statements

 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(all amounts in thousands)

 

 

 

June 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

 

(unaudited)

 

 

(Note 1)

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,240

 

 

$

4,167

 

Accounts receivable, less allowance of $1,104 in 2021 and $1,152 in 2020

 

 

36,270

 

 

 

27,173

 

Inventories

 

 

48,691

 

 

 

50,704

 

Prepaid expenses and other current assets

 

 

2,234

 

 

 

1,642

 

Total current assets

 

 

90,435

 

 

 

83,686

 

Property, plant and equipment:

 

 

 

 

 

 

 

 

Land

 

 

1,768

 

 

 

1,770

 

Buildings

 

 

13,518

 

 

 

12,899

 

Machinery and equipment

 

 

27,455

 

 

 

24,524

 

 

 

 

42,741

 

 

 

39,193

 

Less: accumulated depreciation

 

 

20,332

 

 

 

18,954

 

   Net property, plant and equipment

 

 

22,409

 

 

 

20,239

 

 

 

 

 

 

 

 

 

 

Operating lease right-of-use asset, net

 

 

3,476

 

 

 

2,422

 

Goodwill

 

 

4,800

 

 

 

4,800

 

Intangible assets, less accumulated amortization

 

 

18,019

 

 

 

18,721

 

Total assets

 

$

139,139

 

 

$

129,868

 

 

 

See Notes to Condensed Consolidated Financial Statements

3


 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (continued)

(all amounts in thousands, except share amounts)

 

 

 

June 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

 

(unaudited)

 

 

(Note 1)

 

LIABILITIES

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

8,021

 

 

$

7,601

 

Operating lease liability - current portion

 

 

919

 

 

 

873

 

Current portion of mortgage payable

 

 

267

 

 

 

267

 

Other accrued liabilities

 

 

10,278

 

 

 

11,460

 

Total current liabilities

 

 

19,485

 

 

 

20,201

 

Non-current liabilities:

 

 

 

 

 

 

 

 

Long-term debt

 

 

39,550

 

 

 

38,767

 

Long-term debt - PPP Loan

 

 

-

 

 

 

3,508

 

Mortgage payable, net of current portion

 

 

2,778

 

 

 

2,911

 

Operating lease liability - non-current portion

 

 

2,764

 

 

 

1,654

 

Other non-current liabilities

 

 

110

 

 

 

110

 

Total liabilities

 

 

64,687

 

 

 

67,151

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies (see note 2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Common stock, par value $2.50:

 

 

 

 

 

 

 

 

authorized 8,000,000 shares;

 

 

 

 

 

 

 

 

issued - 5,030,866 shares in 2021 and 4,840,571 in 2020,

 

 

 

 

 

 

 

 

including treasury stock

 

 

12,576

 

 

 

12,101

 

Additional paid-in capital

 

 

10,829

 

 

 

7,931

 

Retained earnings

 

 

66,415

 

 

 

58,033

 

Treasury stock, at cost - 1,501,658 shares in 2021 and 2020

 

 

(14,522

)

 

 

(14,522

)

Accumulated other comprehensive loss:

 

 

 

 

 

 

 

 

Translation adjustment

 

 

(846

)

 

 

(826

)

Total stockholders’ equity

 

 

74,452

 

 

 

62,717

 

Total liabilities and stockholders’ equity

 

$

139,139

 

 

$

129,868

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

 

4


 

 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

(all amounts in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net sales

 

$

44,847

 

 

$

44,042

 

 

$

88,372

 

 

$

79,817

 

Cost of goods sold

 

 

28,694

 

 

 

27,989

 

 

 

56,632

 

 

 

50,234

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

16,153

 

 

 

16,053

 

 

 

31,740

 

 

 

29,583

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

12,364

 

 

 

11,670

 

 

 

24,983

 

 

 

23,191

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

 

3,789

 

 

 

4,383

 

 

 

6,757

 

 

 

6,392

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-operating items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(226

)

 

 

(245

)

 

 

(452

)

 

 

(568

)

Interest income

 

 

3

 

 

 

11

 

 

 

9

 

 

 

14

 

Interest expense, net

 

 

(223

)

 

 

(234

)

 

 

(443

)

 

 

(554

)

PPP loan forgiveness

 

 

3,508

 

 

 

-

 

 

 

3,508

 

 

 

-

 

Other (expense) income, net

 

 

(68

)

 

 

1

 

 

 

(145

)

 

 

(37

)

Total other income (expense), net

 

 

3,440

 

 

 

1

 

 

 

3,363

 

 

 

(37

)

Income before income tax expense

 

 

7,006

 

 

 

4,150

 

 

 

9,677

 

 

 

5,801

 

Income tax (benefit) expense

 

 

(224

)

 

 

951

 

 

 

400

 

 

 

1,325

 

Net income

 

$

7,230

 

 

$

3,199

 

 

$

9,277

 

 

$

4,476

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

2.16

 

 

$

0.96

 

 

$

2.72

 

 

$

1.34

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

1.82

 

 

$

0.92

 

 

$

2.34

 

 

$

1.28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding-denominator used for basic

   per share computations

 

 

3,347

 

 

 

3,349

 

 

 

3,410

 

 

 

3,344

 

Weighted average number of dilutive stock options outstanding

 

 

617

 

 

 

132

 

 

 

551

 

 

 

155

 

Denominator used for diluted per share computations

 

 

3,964

 

 

 

3,481

 

 

 

3,961

 

 

 

3,499

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per share

 

$

0.13

 

 

$

0.12

 

 

$

0.26

 

 

$

0.24

 

 

 

 

See Notes to Condensed Consolidated Financial Statements

5


 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

(all amounts in thousands)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net income

 

$

7,230

 

 

$

3,199

 

 

$

9,277

 

 

$

4,476

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

168

 

 

 

201

 

 

 

(20

)

 

 

(128

)

Comprehensive income

 

$

7,398

 

 

$

3,400

 

 

$

9,257

 

 

$

4,348

 

 

See Notes to Condensed Consolidated Financial Statements

6


 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(UNAUDITED)

(all amounts in thousands, except share amounts)

For the three months ended June 30, 2020

 

 

Outstanding Shares of Common Stock

 

 

Common Stock

 

 

Treasury

Stock

 

 

Additional Paid-In Capital

 

 

Accumulated

Other Comprehensive (Loss) Gain

 

 

Retained Earnings

 

 

Total

 

Balances, March 31, 2020

 

3,340,114

 

 

$

12,094

 

 

$

(14,449

)

 

$

8,048

 

 

$

(2,317

)

 

$

52,448

 

 

$

55,824

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,199

 

 

 

3,199

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

201

 

 

 

 

 

 

 

201

 

Stock compensation expense

 

 

 

 

 

 

 

 

 

 

 

 

 

359

 

 

 

 

 

 

 

 

 

 

 

359

 

Distributions to shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(400

)

 

 

(400

)

Cash settlement of stock options

 

 

 

 

 

 

 

 

 

 

 

 

 

(103

)

 

 

 

 

 

 

 

 

 

 

(103

)

Purchase of treasury stock

 

(3,701

)

 

 

 

 

 

 

(73

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(73

)

Balances June 30, 2020

 

3,336,413

 

 

$

12,094

 

 

$

(14,522

)

 

$

8,304

 

 

$

(2,116

)

 

$

55,247

 

 

$

59,007

 

 

For the three months ended June 30, 2021

 

 

Outstanding Shares of Common Stock

 

 

Common Stock

 

 

Treasury

Stock

 

 

Additional Paid-In Capital

 

 

Accumulated

Other Comprehensive (Loss) Gain

 

 

Retained Earnings

 

 

Total

 

Balances, March 31, 2021

 

3,356,614

 

 

$

12,145

 

 

$

(14,522

)

 

$

8,375

 

 

$

(1,014

)

 

$

59,643

 

 

$

64,627

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,230

 

 

 

7,230

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

168

 

 

 

 

 

 

 

168

 

Stock compensation expense

 

 

 

 

 

 

 

 

 

 

 

 

 

580

 

 

 

 

 

 

 

 

 

 

 

580

 

Distributions to shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(458

)

 

 

(458

)

Issuance of common stock

 

172,594

 

 

 

431

 

 

 

 

 

 

 

2,085

 

 

 

 

 

 

 

 

 

 

 

2,516

 

Cash settlement of stock options

 

 

 

 

 

 

 

 

 

 

 

 

 

(211

)

 

 

 

 

 

 

 

 

 

 

(211

)

Balances June 30, 2021

 

3,529,208

 

 

$

12,576

 

 

$

(14,522

)

 

$

10,829

 

 

$

(846

)

 

$

66,415

 

 

$

74,452

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

For the six months ended June 30, 2020  

     

 

 

Outstanding

Shares of

Common

Stock

 

 

Common

Stock

 

 

Treasury

Stock

 

 

Additional

Paid-In

Capital

 

 

Accumulated

Other

Comprehensive

(Loss) Gain

 

 

Retained

Earnings

 

 

Total

 

Balances, December 31, 2019

 

 

3,350,833

 

 

$

12,094

 

 

$

(14,235

)

 

$

8,262

 

 

$

(1,988

)

 

$

51,571

 

 

$

55,704

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,476

 

 

 

4,476

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(128

)

 

 

 

 

 

 

(128

)

Stock compensation expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

602

 

 

 

 

 

 

 

 

 

 

 

602

 

Distributions to shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(800

)

 

 

(800

)

Cash settlement of stock options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(560

)

 

 

 

 

 

 

 

 

 

 

(560

)

Purchase of treasury stock

 

 

(14,420

)

 

 

 

 

 

 

(287

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(287

)

Balances June 30, 2020

 

 

3,336,413

 

 

$

12,094

 

 

$

(14,522

)

 

$

8,304

 

 

$

(2,116

)

 

$

55,247

 

 

$

59,007

 

 

 

 

 

 

 

7


 

 

For the six months ended June 30, 2021

 

 

 

 

 

Outstanding

Shares of

Common

Stock

 

 

Common

Stock

 

 

Treasury

Stock

 

 

Additional

Paid-In

Capital

 

 

Accumulated

Other

Comprehensive

(Loss) Gain

 

 

Retained

Earnings

 

 

Total

 

Balances, December 31, 2020

 

 

3,338,913

 

 

$

12,101

 

 

$

(14,522

)

 

$

7,931

 

 

$

(826

)

 

$

58,033

 

 

$

62,717

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,277

 

 

 

9,277

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(20

)

 

 

 

 

 

 

(20

)

Stock compensation expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

886

 

 

 

 

 

 

 

 

 

 

 

886

 

Distributions to shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(895

)

 

 

(895

)

Issuance of common stock

 

 

190,295

 

 

 

475

 

 

 

 

 

 

 

2,223

 

 

 

 

 

 

 

 

 

 

 

2,698

 

Cash settlement of stock options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(211

)

 

 

 

 

 

 

 

 

 

 

(211

)

Balances June 30, 2021

 

 

3,529,208

 

 

$

12,576

 

 

$

(14,522

)

 

$

10,829

 

 

$

(846

)

 

$

66,415

 

 

$

74,452

 

 

See Notes to Condensed Consolidated Financial Statements.

8


 

ACME UNITED CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(all amounts in thousands)

 

 

 

Six Months Ended

 

 

 

June 30,

 

 

 

2021

 

 

2020

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

9,277

 

 

$

4,476

 

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

 

1,176

 

 

 

1,125

 

Amortization of intangible assets

 

 

742

 

 

 

659

 

Non-cash lease expense

 

 

43

 

 

 

47

 

Stock compensation expense

 

 

886

 

 

 

602

 

Provision for bad debt

 

 

54

 

 

 

619

 

PPP loan forgiveness

 

 

(3,508

)

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(9,072

)

 

 

(8,598

)

Inventories

 

 

2,007

 

 

 

(4,675

)

Prepaid expenses and other current assets

 

 

(593

)

 

 

(414

)

Accounts payable

 

 

346

 

 

 

1,961

 

Other accrued liabilities

 

 

(1,215

)

 

 

1,845

 

Total adjustments

 

 

(9,134

)

 

 

(6,829

)

Net cash provided by (used in) operating activities

 

 

143

 

 

 

(2,353

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(3,351

)

 

 

(1,323

)

  Acquisition of First Aid Central

 

 

-

 

 

 

(2,074

)

Net cash used in investing activities

 

 

(3,351

)

 

 

(3,397

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net borrowings of long-term debt

 

 

782

 

 

 

2,502

 

Proceeds from PPP Loan

 

 

-

 

 

 

3,508

 

Cash settlement of stock options

 

 

(211

)

 

 

(560

)

Repayments on mortgage

 

 

(133

)

 

 

(133

)

Proceeds from issuance of common stock

 

 

2,698

 

 

 

-

 

Distributions to shareholders

 

 

(871

)

 

 

(800

)

Purchase of treasury shares

 

 

-

 

 

 

(287

)

Net cash provided by financing activities

 

 

2,265

 

 

 

4,230

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

16

 

 

 

(63

)

Net change in cash and cash equivalents

 

 

(927

)

 

 

(1,583

)

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

 

4,167

 

 

 

6,822

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

3,240

 

 

$

5,239

 

 

 

 

 

 

 

 

 

 

Supplemental cash flow information:

 

 

 

 

 

 

 

 

Cash paid for income taxes

 

$

952

 

 

$

371

 

Cash paid for interest

 

$

440

 

 

$

548

 

 

See Notes to Condensed Consolidated Financial Statements

 

9


 

 

ACME UNITED CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Basis of Presentation

The accompanying condensed consolidated financial statements include all adjustments necessary to present fairly the financial position, results of operations and cash flows of Acme United Corporation (the “Company”). These adjustments are of a normal, recurring nature. However, the financial statements do not include all the disclosures normally required by accounting principles generally accepted in the United States of America or those normally made in the Company's Annual Report on Form 10-K. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2020 for such disclosures. The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the financial statements and notes thereto included in the Company’s 2020 Annual Report on Form 10-K.

The Company has evaluated events and transactions subsequent to June 30, 2021 and through the date these condensed consolidated financial statements were issued.

Recently Issued and Adopted Accounting Standards

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update eliminates, clarifies and modifies certain guidance related to the accounting for income taxes. ASU 2019-12 is effective for annual reporting periods beginning after December 15, 2020, i.e. commencing with our current fiscal year.  The adoption of ASU 2019-12 did not have a material effect on the Company’s consolidated financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this update eliminate Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable.  The Company adopted this standard on January 1, 2020. The adoption of this standard has not had an impact on the financial statements of the Company.

 

2. Commitment and Contingencies

There are no pending material legal proceedings to which the Company is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.

3. Revenue from Contracts with Customers

Nature of Goods and Services

The Company recognizes revenue from the sales of a broad line of products that are grouped into two main categories: (a) cutting, sharpening and measuring; and (b) first aid and safety. The cutting, sharpening and measuring category includes scissors, knives, paper trimmers, pencil sharpeners and other sharpening tools. The first aid and safety category includes first aid kits and refills, over-the-counter medications and a variety of safety products. Revenue recognition is evaluated through the following five steps: (i) identification of the contract or contracts with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.

When Performance Obligations Are Satisfied

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.  A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Revenue is generated by the sale of the Company’s products to its customers.  Sales contracts (purchase orders) generally have a single performance obligation that is satisfied at a point in time, with shipment or delivery, depending on the terms of the underlying contract. Revenue is measured based on the consideration specified in the contract. The amount of consideration we receive and revenue we recognize is impacted by incentives ("customer rebates"), including sales rebates, which are generally tied to sales volume levels, in-store promotional allowances, shared media and customer catalogue allowances and other cooperative advertising arrangements; freight allowance programs offered to our customers; and allowance for returns and discounts. We generally recognize customer rebate costs as a deduction to gross sales at the time that the associated revenue is recognized.

10


 

Significant Payment Terms

Payment terms for each customer are dependent on the agreed upon contractual repayment terms. Payment terms typically are between 30 and 90 days and vary depending on the size of the customer and its risk profile to the Company. Some customers receive discounts for early payment.

Product Returns

The Company accepts product returns in the normal course of business. The Company estimates reserves for returns and the related refunds to customers based on historical experience. Reserves for returned merchandise are included as a component of “Accounts receivable” in the condensed consolidated balance sheets.

Practical Expedient Usage and Accounting Policy Elections

For the Company’s contracts that have an original duration of one year or less, the Company uses the practical expedient in ASC 606-10-32-18 applicable to such contracts and does not consider the time value of money in relation to significant financing components.  The effect of applying this practical expedient election did not have an impact on the Company’s condensed consolidated financial statements.  

Per ASC 606-10-25-18B, the Company has elected to account for shipping and handling activities that occur after the customer has obtained control as a fulfilment activity instead of a performance obligation. Furthermore, shipping and handling activities performed before transfer of control of the product also do not constitute a separate and distinct performance obligation. The effect of applying this practical expedient election did not have an impact on the Company’s condensed consolidated financial statements.  

The Company has elected to exclude from the transaction price those amounts which relate to sales and other taxes that are assessed by governmental authorities and that are imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer.

Applying the practical expedient in ASC 340-40-25-4, Other Assets and Deferred Costs, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred. These costs are included in “Selling, general and administrative expenses.” The effect of applying this practical expedient did not have an impact on the Company’s condensed consolidated financial statements.

Disaggregation of Revenues

The following table represents external net sales disaggregated by product category, by segment (amounts in thousands):

For the three months ended June 30, 2021

 

 

 

United States

 

 

Canada

 

 

Europe

 

 

Total

 

Cutting, Sharpening and Measuring

 

$

16,162

 

 

$

2,091

 

 

$

3,677

 

 

$

21,930

 

First Aid and Safety

 

 

20,678

 

 

 

1,899

 

 

$

340

 

 

 

22,917

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

36,840

 

 

$

3,990

 

 

$

4,017

 

 

$

44,847

 

 

For the three months ended June 30, 2020

 

 

 

United States

 

 

Canada

 

 

Europe

 

 

Total

 

Cutting, Sharpening and Measuring

 

$

19,699

 

 

$

1,247

 

 

$

2,891

 

 

$

23,837

 

First Aid and Safety

 

 

18,773

 

 

 

1,141

 

 

 

291

 

 

 

20,205

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

38,472

 

 

$

2,388

 

 

$

3,182

 

 

$

44,042

 

 

For the six months ended June 30, 2021

 

 

 

U.S.

 

 

Canada

 

 

Europe

 

 

Total

 

Cutting, Sharpening and Measuring

 

$

31,726

 

 

$

3,640

 

 

$

7,420

 

 

$

42,786

 

First Aid and Safety

 

 

41,162

 

 

 

3,683

 

 

 

741

 

 

 

45,586

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

72,888

 

 

$

7,323

 

 

$

8,161

 

 

$

88,372

 

 

 

 

 

11


 

 

For the six months ended June 30, 2020

 

 

 

U.S.

 

 

Canada

 

 

Europe

 

 

Total

 

Cutting, Sharpening and Measuring

 

$

31,427

 

 

$

2,661

 

 

$

5,497

 

 

$

39,585

 

First Aid and Safety

 

 

37,488

 

 

 

2,141

 

 

 

603

 

 

 

40,232

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

68,915

 

 

$

4,802

 

 

$

6,100

 

 

$

79,817

 

 

 

4. Debt and Shareholders’ Equity

Long-term debt consists of borrowings under the Company’s revolving loan agreement with HSBC Bank, N.A. The agreement provides for borrowings of up to $50 million at Prime Rate less 1.25%. The credit facility has an expiration date of May 24, 2023. The Company must pay a facility fee, payable quarterly, in an amount equal to two tenths of one percent (.20%) per annum of the average daily unused portion of the revolving credit line.  The facility is intended to provide liquidity for working capital, growth, dividends, acquisitions, share repurchases and other business activities.  Under the revolving loan agreement, the Company is required to maintain specific amounts of tangible net worth, a specified debt to net worth ratio and a fixed charge coverage ratio and must have annual net income greater than zero, measured as of the end of each fiscal year. As of June 30, 2021, the Company was in compliance with the covenants then in effect under the loan agreement.  

As of June 30, 2021, and December 31, 2020, the Company had outstanding borrowings of $39,550,000 and $38,767,000, respectively, under the Company’s revolving loan agreement with HSBC.

On October 26, 2017, the Company exercised its option to purchase its First Aid Only manufacturing and distribution center in Vancouver, WA for $4.0 million. The property consists of 53,000 square feet of office, manufacturing, and warehouse space on 2.86 acres. The purchase was financed by a variable rate mortgage with HSBC Bank, N.A. at an interest rate of LIBOR plus 2.5%. Commencing on December 1, 2017, principal payments of $22,222 are due monthly, with all amounts outstanding due on maturity on October 31, 2024.

During the three months ended June 30, 2021, the Company issued a total of 172,594 shares of common stock and received aggregate proceeds of $2,517,000 upon exercise of employee stock options. During the six months ended June 30, 2021, the Company issued a total of 190,295 shares of common stock and received aggregate proceeds of $2,698,000 upon exercise of employee stock options. Also during the three and six months ended June 30, 2021, the Company, at its discretion, paid approximately $211,000 to optionees who had elected (subject to the approval of the Company) a net cash settlement of their respective options.  

Also included in long term debt at December 31,2020 was the amount then outstanding under a Paycheck Protection Program (PPP) loan; the loan was forgiven in the quarter ended June 30, 2021. See Note 9 – Paycheck Protection Program Loan for additional details.   

5. Segment Information

The Company reports financial information based on the organizational structure used by the Company’s chief operating decision makers for making operating and investment decisions and for assessing performance. The Company’s reportable business segments consist of: (1) United States; (2) Canada; and (3) Europe. As described below, the activities of the Company’s Asian operations are closely linked to those of the U.S. operations; accordingly, the Company’s chief operating decision makers review the financial results of both on a consolidated basis, and the results of the Asian operations have been aggregated with the results of the United States operations to form one reportable segment called the “United States segment” or “U.S. segment”. Each reportable segment derives its revenue from the sales of cutting and sharpening devices, measuring instruments and first aid and safety products for school, office, home, hardware, sporting and industrial use.

Domestic sales orders are filled primarily from the Company’s distribution centers in North Carolina, Washington, Massachusetts, Tennessee, Florida and California. The Company is responsible for the costs of shipping, insurance, customs clearance, duties, storage and distribution related to such products. Orders filled from the Company’s inventory are generally for less than container-sized lots.

Direct import sales are products sold by the Company’s Asian subsidiary, directly to major U.S. retailers, who take ownership of the products in Asia. These sales are completed by delivering product to the customers’ common carriers at the shipping points in Asia. Direct import sales are made in larger quantities than domestic sales, typically full containers. Direct import sales represented approximately 10% and 8% of the Company’s total net sales for the three and six months ended June 30, 2021, compared to 14% and 11% for the comparable period in 2020.

The Chief Operating Decision Maker evaluates the performance of each operating segment based on segment revenues and operating income. Segment revenues are defined as total revenues, including both external customer revenue and inter-segment revenue. Segment operating earnings are defined as segment revenues, less cost of goods sold and operating expenses. Identifiable assets by segment are those assets used in the respective reportable segment’s operations. Inter-segment amounts are eliminated to arrive at consolidated financial results.

12


 

The following table sets forth certain financial data by segment for three and six months ended June 30, 2021 and 2020:

Financial data by segment:

(in thousands)

 

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

Sales to external customers:

 

2021

 

 

2020

 

 

2021

 

 

2020

 

United States

 

$

36,840

 

 

$

38,476

 

 

$

72,888

 

 

$

68,922

 

Canada

 

 

3,990

 

 

 

2,381

 

 

 

7,322

 

 

 

4,800

 

Europe

 

 

4,017

 

 

 

3,185

 

 

 

8,162

 

 

 

6,095

 

Consolidated

 

$

44,847

 

 

$

44,042

 

 

$

88,372

 

 

$

79,817

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

2,675

 

 

$

3,685

 

 

$

4,807

 

 

$

5,253

 

Canada

 

 

662

 

 

 

366

 

 

 

1,034

 

 

 

573

 

Europe

 

 

452

 

 

 

332

 

 

 

916

 

 

 

566

 

Consolidated

 

$

3,789

 

 

$

4,383

 

 

$

6,757

 

 

$

6,392

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(223

)

 

 

(234

)

 

 

(443

)

 

 

(554

)

Other income (expense), net

 

 

3,440

 

 

 

1

 

 

 

3,363

 

 

 

(37

)

Consolidated income before income taxes

 

$

7,006

 

 

$

4,150

 

 

$

9,677

 

 

$

5,801

 

 

Assets by segment:

(in thousands)

 

 

 

June 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

United States

 

$

120,848

 

 

$

113,831

 

Canada

 

 

8,722

 

 

 

7,432

 

Europe

 

 

9,569

 

 

 

8,605

 

Consolidated

 

$

139,139

 

 

$

129,868

 

 

6. Stock Based Compensation

The Company recognizes share-based compensation at the fair value of the equity instrument on the grant date. Compensation expense is recognized over the required service period, which is generally the vesting period of the equity instrument. Share-based compensation expense was $580,000 and $886,000 for the three and six months ended June 30, 2021, respectively, compared to $359,000 and $602,000 for the three and six months ended June 30, 2020, respectively.

As of June 30, 2021, there was a total of $1,730,226 of unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested share-based payments granted to the Company’s employees. As of that date, the remaining unamortized expense was expected to be recognized over a weighted average period of approximately three years.

7. Fair Value Measurements

The carrying value of the Company’s bank debt is a reasonable estimate of fair value because of the nature of its payment terms and maturity.

8. Leases

The Company has operating leases for office and warehouse space and equipment under various arrangements which provide the right to use the underlying asset and require lease payments for the lease term. The Company’s lease portfolio consists of operating leases which expire at various dates through 2026.

Certain of the Company’s lease arrangements contain renewal provisions, exercisable at the Company's option. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

The Company determines if an arrangement is an operating lease at inception. Leases with an initial term of 12 months or less are not recorded on the balance sheet. All other leases are recorded on the balance sheet with right-of-use (“ROU”) assets representing the right to use the underlying asset for the lease term and lease liabilities representing the obligation to make lease payments arising from the lease.

13


 

ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term and include options to extend or terminate the lease when they are reasonably certain to be exercised. As most of our leases do not provide an implicit rate, the present value of lease payments is determined primarily using our incremental borrowing rate based on the information available at the lease commencement date. The incremental borrowing rate is the rate of interest that we would have to pay to borrow on a collateralized basis over a similar term on an amount equal to the lease payments in a similar economic environment.  Lease agreements with lease and non-lease components are generally accounted for as a single lease component. The Company’s operating lease expense is recognized on a straight-line basis over the lease term.  For the three months ended June 30, 2021, lease expense in the amount of $0.1 million was included in cost of goods sold and $0.2 million was included in selling, general and administrative expenses in the accompanying condensed consolidated statement of operations. For the six months ended June 30, 2021, lease expense in the amount of $0.2 million was included in cost of goods sold and $0.4 million was included in selling, general and administrative expenses in the accompanying condensed consolidated statement of operations.                             

Information related to leases (in thousands):

 

 

 

Three months ended

 

 

Three months ended

 

Operating cash flow information:

 

June 30, 2021

 

 

June 30, 2020

 

Operating lease cost

 

$

336

 

 

$

308

 

Operating lease - cash flow

 

$

294

 

 

$

296

 

 

 

 

 

 

 

 

 

 

Non-cash activity:

 

 

 

 

 

 

 

 

ROU assets obtained in exchange for lease liabilities

 

$

-

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended

 

 

Six months ended

 

Operating cash flow information:

 

June 30, 2021

 

 

June 30, 2020

 

Operating lease cost

 

$

672

 

 

$

615

 

Operating lease - cash flow

 

$

588

 

 

$

567

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash activity:

 

 

 

 

 

 

 

 

ROU assets obtained in exchange for lease liabilities

 

$

1,575

 

 

$

-

 

 

 

 

June 30, 2021

 

 

June 30, 2020

 

Weighted-average remaining lease term

 

4.0 years

 

 

4.0 years

 

Weighted-average discount rate

 

 

5

%

 

 

5

%

 

Future minimum lease payments under non-cancellable leases as of June 30, 2021:

 

2021 (remaining)

 

$

511

 

2022

 

 

1,084

 

2023

 

 

964

 

2024

 

 

703

 

2025

 

 

613

 

Thereafter

 

 

140

 

 

 

 

 

 

Total future minimum lease payments

 

$

4,015

 

Less: imputed interest

 

 

(332

)

Present value of lease liabilities - current

 

 

919

 

Present value of lease liabilities - non-current

 

$

2,764

 

 

 

9. Paycheck Protection Program Loan

 

On May 7, 2020, the Company received a two-year loan (the “PPP Loan”) from HSBC Bank USA, N.A., the lender, in the amount of $3,508,047 under the Paycheck Protection Program established by the Coronavirus Aid, Relief and Economic Security Act (CARES Act).  Monthly payments of principal and interest were deferred until the application for forgiveness submitted by the Company had been acted upon, as described below.  

Under the CARES Act, all or a portion of the PPP Loan was eligible to be forgiven by the U.S. Small Business Administration (“SBA”) and the lender, upon application by the Company, provided that the Company shall have used the loan proceeds for certain eligible purposes.  The Company used the loan proceeds solely for payment of payroll and otherwise in a manner which it believed would satisfy the requirements for

14


 

loan forgiveness.  In August 2020, the Company submitted an application for forgiveness of the entire amount of the PPP Loan to the lender.  The lender approved the forgiveness application and, on August 26, 2020, submitted the Company’s application to the SBA for its approval. The PPP Loan was fully forgiven by the SBA and on June 9, 2021, payment in the amount of $3,508,047 was made by the SBA to the lender.   The Company recorded the amount forgiven as income in the quarter ended June 30, 2021.

 

10. Other Accrued Liabilities

 

Other current accrued liabilities consisted of (in thousands):

 

 

 

June 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Customer Rebates

 

$

5,989

 

 

$

6,068

 

Accrued Compensation

 

 

1,094

 

 

 

3,072

 

Dividend Payable

 

 

458

 

 

 

435

 

Other

 

 

2,737

 

 

 

1,885

 

Total:

 

$

10,278

 

 

$

11,460

 

 

 

 

 

 

 

 

 

 

 

15


 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Information

The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.

Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results, including the global COVID-19 pandemic, future waves of COVID-19, including through the Delta variant and any new variant strains of the underlying virus; any future pandemics; the effectiveness  and public acceptance of existing vaccines; the effectiveness, availability, and public acceptance of vaccines against variant strains of potential new viruses; the pace of economic recovery and accelerating inflation, and the heightened impact the pandemic has on many of the risks described herein, including without limitation risks relating to disruptions in our supply chain and labor force, any of which could adversely impact the Company’s ability to manufacture, source or distribute its products, both domestically and internationally.    

These risks and uncertainties further include, without limitation, the following:  (i) changes in the Company’s plans, strategies, objectives, expectations and intentions,  which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, whether caused by COVID-19 or otherwise, including the impact on the Company’s suppliers and customers; (iii) changes in client needs and consumer spending habits; (iv) the impact of competition; (v) the impact of technological changes including, specifically, the growth of online marketing and sales activity; (vi) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (vii) the Company’s ability to effectively manage its inventory in a rapidly changing business environment, including additional inventory acquired to respond to COVID-19 related uncertainties; (viii) rising wages; (ix) labor shortages; (x) rising inflation rates; (xi) currency fluctuations;  (xii) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (xiii) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

For a more detailed discussion of these and other factors affecting the Company, see the Risk Factors described in Item 1A included in the Company’s Annual Report on Form 10-K for the fiscal year December 31, 2020 and below under “Financial Condition”. All forward-looking statements in this report are based upon information available to the Company on the date of this report. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Critical Accounting Policies

We discuss our critical accounting policies and estimates in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

 

COVID-19 Pandemic Related Considerations

 

As noted above in the “Forward-Looking Statements”, the global spread of the coronavirus (COVID-19) and the related economic recovery continue to present certain significant risks and uncertainties to the Company and its operations. Commencing late in the first quarter of 2020 and continuing through the filing of this report, the COVID-19 pandemic and the ongoing recovery has affected the Company’s financial results and business operations.  Although the Company gained market share in its Westcott craft products, it has experienced and continues to experience weakness in the sales of its Westcott office and school supplies due, in part, to pandemic-related closures of schools and offices.  The Company has also been impacted by challenges in hiring employees for its distributions centers due to current domestic labor shortages and has incurred increased labor costs.  In addition, the Company had to acquire and subsequently maintain additional inventory to minimize the impact of any potential disruption to our supply chain. The ultimate impact of these effects on the Company will depend on the continued duration, spread, and severity of the COVID-19 pandemic, and any further recurrence including through the Delta variant and any new variant strains of the underlying virus, the effectiveness, and acceptance by the public of vaccines, and the pace of the economic recovery.  

Substantially all of our manufacturing facilities and distribution centers and those of our key suppliers have remained open throughout the pandemic and continue to operate. We monitor information on COVID-19 from the Centers for Disease Control and Prevention (“CDC”) and believe we are adhering to their recommendations regarding the health and safety of our personnel. To address the potential human impact of the virus, most of our administrative staff is continuing to telecommute. With respect to our warehouse and domestic manufacturing employees,

16


 

we continue to require masks, encourage vaccination, and have implemented other safety protocols. Domestic and international travel for our employees has continued to be restricted.    We continue to have higher turnover compared to prepandemic levels.  As a result of the foregoing factors, we continue to operate at a less efficient level as compared with our prepandemic operations.

The Company anticipates that it has sufficient inventory of its products to meet anticipated demand. However, any further increase in the duration or severity of the COVID-19 pandemic or a resurgence of the pandemic in the future and the pace at which the economy recovers, might adversely affect the Company’s ability to manufacture, source or distribute its products both domestically and internationally. The occurrence of any of these factors could have a material adverse effect on the Company’s business, operations and financial condition.  

Results of Operations

Traditionally, the Company’s sales are stronger in the second and third quarters and weaker in the first and fourth quarters of the fiscal year, due to the seasonal nature of the back-to-school market.

Net sales

Consolidated net sales for the three months ended June 30, 2021 were $44,847,000 compared with $44,042,000 in the same period in 2020, a 2% increase. Consolidated net sales for six months ended June 30, 2021 were $88,372,000 compared with $79,817,000 in the same period in 2020, an 11% increase.

Sales in the U.S. for the three and six months ended June 30, 2021 decreased 4% and increased 6%, respectively, compared to the same periods in 2020. The decrease in sales for the three months was due to delays in shipping that resulted from the scheduled closing of the Rocky Mount, NC distribution center as the Company’s new warehouse management system was installed.  The increase in sales for the six months was primarily attributable to strong sales of first aid and safety products.

Net sales in Canada for the three and six months ended June 30, 2021, increased 68% and 53%, respectively, in U.S. dollars and 51% and 26% in local currency compared to the same periods last year. The increases in sales were primarily due to higher sales of First Aid Central products, principally in the e-commerce channels, as well as increased sales of school and office products compared to the sales of such products during the COVID-19 lockdowns in the second quarter 2020.     

European net sales for the three and six months ended June 30, 2021 increased 26% and 34%, respectively, in U.S. dollars (16% and 23% in local currency), compared with the same period in 2020. The increase in net sales for the three months was mainly due to re-opening of offices and growth in the e-commerce channel across all product lines. The increase in net sales for the six months was primarily due to growth in the e-commerce channel across all product lines and continued growth of DMT sharpening products.

 

Gross profit

 

Gross profit for the three months ended June 30, 2021 was $16,153,000 (36.0% of net sales) compared to $16,053,000 (36.4% of net sales) in the same period in 2020. Gross profit for the six months ended June 30, 2021 was $31,740,000 (35.9% of net sales) compared to $29,583,000 (37.1% of net sales) for the same period in 2020. The lower gross profit percentages were mainly due to product mix and higher ocean freight costs which the Company incurred as a result of scarcity of shipping containers and congestion at global ports as well as higher labor costs.

 

Selling, general and administrative expenses

 

Selling, general and administrative ("SG&A") expenses for the three months ended June 30, 2021 were $12,364,000 (27.6% of net sales) compared with $11,670,000 (26.5% of net sales) in the same period in 2020, an increase of $694,000. SG&A expenses for the six months ended June 30, 2021 were $24,983,000 (28.3% of net sales) compared with $23,191,000 (29.1% of net sales) for the same periods of 2020, an increase of $1,792,000. The increases in SG&A expenses for three and six months ended June 30, 2021, compared to the same period in 2020 were primarily due to higher personnel related costs, commissions and shipping costs related to higher sales (including costs resulting from the absorption of Med Nap personnel).

 

Operating income

 

Operating income for the three months ended June 30, 2021 was $3,789,000 compared with $4,383,000 in the same period of 2020. Operating income for the six months ended June 30, 2021 was $6,757,000 compared with $6,392,000 in the same period of 2020. Operating income in the U.S. segment decreased by $1,010,000 and $446,000 for the three and six months ended June 30, 2021, respectively, compared to the same periods in 2020.

 

Operating income in the Canadian segment increased by $296,000 and $461,000 for the three and six months ended June 30, 2021, respectively, compared to the same periods in 2020.

17


 

 

Operating income in the European segment increased by $120,000 and $350,000 for the three and six months ended June 30, 2021, respectively, compared to the same period in 2020.

 

Interest expense, net

 

Interest expense, net for the three months ended June 30, 2021 was $223,000 compared with $234,000 in the same period of 2020, a $11,000 decrease. Interest expense, net for the six months ended June 30, 2021 was $443,000 compared with $554,000 for the same period of 2020, a $111,000 decrease. The decreases in interest expense resulted from a lower average interest rate partially offset by higher average debt outstanding under the Company’s revolving credit facility.

  

Other income (expense), net

 

Total Other income (expense), net was $3,440,000 in the three months ended June 30, 2021 compared $1,000 in the same period of 2020. Total Other income (expense), net was $3,363,000 in the six months ended June 30, 2021 compared to $37,000 in the same period of 2020.The increase in other income, net for the three and six months ended June 30, 2021, was primarily due to $3,508,047 of income related to the forgiveness of the PPP Loan.  

 

Income taxes

Income tax expense for the three and six months ended June 30, 2021 included a $0.9 million tax credit for stock based compensation. The Company’s effective tax rates for the three and six months ended June 30, 2021, excluding the tax credit and the income from the PPP loan forgiveness, were 19% and 21%, compared to 23% and 21% in the same periods in 2020.

Financial Condition

Liquidity and Capital Resources

 

During the first six months of 2021, working capital increased approximately $7.5 million compared to December 31, 2020. Inventory decreased approximately $2.0 million at June 30, 2021 compared to December 31, 2020. Inventory turnover, calculated using a twelve-month average inventory balance, was 2.4 at June 30, 2021 compared to 2.4 at December 31, 2020.  Receivables increased by approximately $9.1 million at June 30, 2021 compared to December 31, 2020.  The average number of days sales outstanding in accounts receivable was 60 days at each of June 30, 2021 and December 31, 2020.  Accounts payable and other current liabilities decreased by approximately $.7 million at June 30, 2021 compared to December 31, 2020.

The Company's working capital, current ratio and long-term debt to equity ratio are as follows (dollar amounts in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Working capital

 

$

70,950

 

 

$

63,484

 

Current ratio

 

 

4.64

 

 

 

4.14

 

Long term debt to equity ratio

 

 

57.1

%

 

 

72.0

%

 

During the first six months of 2021, total debt outstanding under the Company’s revolving credit facility increased by approximately $0.8 million, compared to total debt thereunder at December 31, 2020. As of June 30, 2021, $39,550,000 was outstanding and $10,450,000 was available for borrowing under the Company’s credit facility.

Long-term debt consists of borrowings under the Company’s revolving loan agreement with HSBC Bank, N.A. as well as amounts outstanding under the variable rate mortgage related on the Company’s manufacturing and distribution facility in Vancouver, WA. At June 30, 2021, there was approximately $3.2 million outstanding on the mortgage. The revolving loan agreement provides for borrowings of up to $50 million at Prime Rate less 1.25%. The credit facility has an expiration date of May 24, 2023. The Company must pay a facility fee, payable quarterly, in an amount equal to two tenths of one percent (.20%) per annum of the average daily unused portion of the revolving credit line. The facility is intended to provide liquidity for working capital, growth, dividends, acquisitions, share repurchases and other business activities.  Under the revolving loan agreement, the Company is required to maintain specific amounts of tangible net worth, a specified debt to net worth ratio and a fixed charge coverage ratio and must have annual net income greater than zero, measured as of the end of each fiscal year. At June 30, 2021, the Company was in compliance with the covenants then in effect under the loan agreement.  

As described above, commencing late in the first quarter of 2020, the Company has encountered challenges as a result of the COVID-19 pandemic and related economic downturn that could have adverse consequences for our liquidity as a result of a number of factors.  As stated

18


 

above, the Company continues to experience weakened sales of school and office products.  Additionally, as noted above, the Company has incurred and continues to incur increased operational and other expenses as a result of the COVID-19 pandemic.  As discussed above, it is possible that the Company’s sourcing of products may be disrupted if the operations of the Company’s suppliers, particularly those located in China, are interrupted by the effects of COVID-19.  In order to address problems that may arise as a result of any such potential disruption, the Company has increased its inventory of Westcott cutting and other products above customary levels.

On May 7, 2020, the Company received a two-year loan (the “PPP Loan”) from HSBC Bank USA, N.A., the lender, in the amount of $3,508,047 under the Paycheck Protection Program established by the Coronavirus Aid, Relief and Economic Security Act (CARES Act).  Monthly payments of principal and interest were deferred until the application for forgiveness submitted by the Company had been acted upon, as described below.  

Under the CARES Act, all or a portion of the PPP Loan was eligible to be forgiven by the U.S. Small Business Administration (“SBA”) and the lender, upon application by the Company, provided that the Company shall have used the loan proceeds for certain eligible purposes.  The Company used the loan proceeds solely for payment of payroll and otherwise in a manner which it believed would satisfy the requirements for loan forgiveness.  In August 2020, the Company submitted an application for forgiveness of the entire amount of the PPP Loan to the lender.  The lender approved the forgiveness application and, on August 26, 2020, submitted the Company’s application to the SBA for its approval. The PPP Loan was fully forgiven by the SBA and on June 9, 2021, payment in the amount of $3,508,047 was made by the SBA to the lender.   The Company recorded the amount forgiven as income in the quarter ended June 30, 2021.

The Company believes that cash generated from operating activities, together with funds available under its revolving credit facility, will, under current conditions, be sufficient to finance the Company’s operations over the next twelve months from the filing of this report.

19


 

Item 3: Quantitative and Qualitative Disclosure about Market Risk

Not applicable.

Item 4: Controls and Procedures

(a)

Evaluation of Internal Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of June 30, 2021. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were not effective as of June 30, 2021 as a result of an identified material weakness.  As described in the Company's Form 10-K for the year ended December 31, 2020, the Company’s controls related to the existence of inventory at the Rocky Mount, NC warehouse (the “Warehouse”) were not effective as the cycle count program used did not demonstrate that inventory quantities were sufficiently counted. The Company's remediation efforts related to this material weakness are ongoing. Except as described below, there were no changes in the Company’s internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

This material weakness did not result in any misstatement of the Company's consolidated financial statements for any period presented.  Our independent public accounting firm, Marcum LLP, audited our consolidated financial statements at December 31, 2020, and for each of the two years in the period ended December 31, 2020, and its report expressed an unqualified opinion on our consolidated financial statements.

(b)

Changes in Internal Control over Financial Reporting

In response to the material weakness identified above, the Company has implemented changes to its internal control over financial reporting, including:

 

●  The Company has evaluated the processes, procedures and controls related to the Warehouse cycle count program and has commenced making changes as considered appropriate to address the control deficiency.

 

●  In the second quarter of 2021, the Company completed the installation of a new inventory management system at the Warehouse, which is expected to be in place by the end of the second quarter 2021.  The new software in intended to enable the Company to conduct its inventory cycle count program more efficiently and effectively.

 

●  The Company continues to allocate additional resources to the implementation of its inventory cycle count program, including the hiring of additional personnel who will participate in the conduct of the program.

 

As stated in the Company’s Form 10-K for the year ended December 31, 2020, we believe that these ongoing actions will remediate the material weakness. However, due to the nature of the material weakness, it will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We expect that the remediation of this material weakness will be completed as of December 31, 2021.

 

20


 

 

PART II. OTHER INFORMATION

There are no pending material legal proceedings to which the registrant is a party, or, to the actual knowledge of the Company, contemplated by any governmental authority.

Item 1A — Risk Factors

See Risk Factors set forth in Part I, Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3 — Defaults upon Senior Securities

None.

Item 4 — Mine Safety Disclosures

Not applicable.

Item 5 — Other Information

None.

Item 6 — Exhibits

Documents filed as part of this report:

 

Exhibit 31.1

 

Certification of Walter C. Johnsen pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

Exhibit 31.2

 

Certification of Paul G. Driscoll pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

Exhibit 32.1

 

Certification of Walter C. Johnsen pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

Exhibit 32.2

 

Certification of Paul G. Driscoll pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

  101.INS

 

Inline XBRL Instance Document.

  101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

  101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

  101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

  101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document.

  101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

104

 

The cover page for the Company’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101

 

21


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

ACME UNITED CORPORATION

 

 

 

By

/s/ Walter C. Johnsen

 

 

Walter C. Johnsen

 

 

Chairman of the Board and

 

 

Chief Executive Officer

 

 

 

 

Dated: August 6, 2021

 

 

By

/s/ Paul G. Driscoll

 

 

Paul G. Driscoll

 

 

Vice President and

 

 

Chief Financial Officer

 

 

 

 

Dated: August 6, 2021

 

 

22